Evidence map›Paper›PMID 24518280›Full record

Trial reportJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2014

Effect of a dietary intervention on growth and energy expenditure in children with cystic fibrosis.

Veronique Groleau, Joan I Schall, Kelly A Dougherty, Norma E Latham, Asim Maqbool, Maria R Mascarenhas, Virginia A Stallings

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Pediatric Bone Mineral Accrual Z-Score Calculation Equations and Their Application in Childhood Disease.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Impact of lumacaftor/ivacaftor on nutrition and growth in modulator-naïve children over 24 weeks.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2024
    Article
  7. Quality of anthropometric data measured in children and adolescents with cystic fibrosis: a scoping review.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2023
    Article
  8. Review
  9. Utility of Mid-Upper Arm Circumference in Diagnosing Malnutrition in Children With Cystic Fibrosis.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2020
    Observational
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Veronique GroleauDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, 3535 Market Street, Room 1558, Philadelphia, PA 19104, USA; Division of Gastroenterology, Hepatology and Nutrition, Ste-Justine University Hospital Center, Montreal, QC, Canada; University of Montreal, Montreal, QC, Canada. Electronic address: veronique.groleau@umontreal.ca.
Joan I SchallDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, 3535 Market Street, Room 1558, Philadelphia, PA 19104, USA.
Kelly A DoughertyDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, 3535 Market Street, Room 1558, Philadelphia, PA 19104, USA; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Norma E LathamDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, 3535 Market Street, Room 1558, Philadelphia, PA 19104, USA.
Asim MaqboolDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, 3535 Market Street, Room 1558, Philadelphia, PA 19104, USA; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Maria R MascarenhasDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, 3535 Market Street, Room 1558, Philadelphia, PA 19104, USA; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Virginia A StallingsDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, 3535 Market Street, Room 1558, Philadelphia, PA 19104, USA; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Children's Hospital of Philadelphia · US

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
Organized Lipid Matrix: Fatty Acids and Choline in Cystic FibrosisR44DK060302 · NIDDK · AVANTI POLAR LIPIDS, INC. · PI SHAW, WALTER A · 2006 to 2008
$6.2M
NCRR NIH HHS UL1 RR024134NCRR NIH HHS UL1RR024134NIDDK NIH HHS R44 DK060302NIDDK NIH HHS R44DK060302
6 · The paper itself

Abstract

backgroundThe study aim was to determine the effect of a dietary intervention on growth, body composition and resting energy expenditure (REE) in children with cystic fibrosis (CF) and pancreatic insufficiency (PI) in a randomized, double blind, placebo-controlled trial.

methodsSubjects (5 to 17 yrs) participated in a 12-month trial of the organized lipid matrix LYM-X-SORB™ (LXS) vs. placebo dietary supplements with similar calories, total fat and fatty acids. Dietary intake was assessed using 3-day weighed food records. Height (HAZ), weight (WAZ), BMI (BMIZ), mid-upper arm muscle (UAMAZ) and fat area (UAFAZ) Z-scores were calculated. Fat mass (FM) and fat-free mass (FFM) were obtained by whole body DXA. REE (kcal/d) was evaluated by indirect calorimetry at baseline, 3 and 12 months and %REE calculated using Schofield equations. No growth or REE differences were observed between LXS and placebo groups so data were pooled for analysis.

results63 children (57% males, age 10.6 ± 2.9 yr, 43% receiving LXS) completed REE measurements. Caloric intake increased from a median of 2502 [1478, 4909] to 2616 [1660, 4125] kcal/d at 12 months. HAZ, WAZ and UAMAZ increased (p < 0.05) over 12 months. Mean REE was 109 ± 8% predicted at baseline and 107 ± 9% at 12 months (p < 0.05). REE (kcal/d) adjusted for FFM and FM decreased over 12 months ([mean ± SE] -31 ± 12 kcals, p < 0.01), significant only in males (-49 ± 16 kcals, p < 0.01).

conclusionsOver a 12 month nutrition intervention with either LXS or placebo, the growth status, muscle stores and REE improved. Sustained increased energy intake improved energy metabolism, growth and nutritional status in school age children with CF, PI and mild lung disease.

Indexed as

Energy MetabolismAdolescentBody CompositionChildChild, PreschoolCystic FibrosisDouble-Blind MethodEnergy IntakeExocrine Pancreatic InsufficiencyFemaleGrowthHumansLung DiseasesMaleChildrenCystic fibrosisDietary interventionResting energy expenditure

Identifiers

PMID24518280
PMCPMC4126892
OpenAlexW2085118183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.